Costco Is Recalling Almost 80,000 Pounds Of Butter. Here's What You Need To Know
The beloved Kirkland Signature brand is under fire for its recent recall of many of its butter offerings. Here's everything ...
pharmaphorum14h
J&J bids to add smouldering myeloma to Darzalex label
The marketing applications with the EMA and FDA are for J&J and partner Genmab's Darzalex Faspro version of the anti-CD38 ...
FDA recalls nearly 80,000 pounds of butter from Costco stores in Texas. Here's what to throw out.
The U.S. Food and Drug Administration's recall concerns two butter products produced by Continental Dairy ...
Supplement Recalls: FDA Warns of Products With 'Hidden Drug Ingredient'
The unlisted ingredients can cause "life threatening" drops in blood pressure when used in combination with other prescription drugs.
WXYZ Detroit 7, MI on MSN3d
FDA adds new warning to popular weight loss drugs
The Food and Drug Administration has updated labels for popular weight loss drugs like Ozempic and Wegovy. NFL News: ...
FDA adds new warning to weight loss drugs including Wegovy
The FDA is warning that patients taking GLP-1s may be at a higher risk of inhaling fluid into their lungs while under ...
verywellhealth3d
Why Listeria Seems to Be Everywhere Now, According to Food Safety Experts
Learn why Listeria-related food recalls are making headlines, how improved detection methods play a role, and what this means ...
What to Know About the 2024 Cheese Recall Due to Listeria Concerns
Listeria can cause an intestinal illness or an invasive illness (meaning, it spreads beyond the gut). The most common symptoms of an intestinal listeria infection are diarrhea and vomiting that start ...
Becker's Hospital Review4d
FDA adds warning to Ozempic, Mounjaro and other GLP-1 labels
The FDA has updated the labels for all GLP-1 receptor agonists, including popular medications Ozempic, Wegovy, Saxenda and Mounjaro, to include a new warning about the risk of pulmonary aspiration ...
BeiGene: TEVIMBRA European Push Continues With Positive CHMP Opinion
BeiGene's TEVIMBRA expands for cancer treatment, and BRUKINSA sales soar 107%. See why BGNE stock presents upside potential ...
The American Journal of Managed Care4d
Fidanacogene Elaparvovec Shows Strong Results in Open-Label Phase 3 Study
The gene therapy improved annualized bleed rates, though a handful of study participants resumed factor IX prophylaxis.